Stay updated on MGD013 and Brivanib in Liver Cancer Clinical Trial
Sign up to get notified when there's something new on the MGD013 and Brivanib in Liver Cancer Clinical Trial page.

Latest updates to the MGD013 and Brivanib in Liver Cancer Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedVersion 6 (2024-06-26) was added, showing updates to Study Status, Study Design, Outcome Measures, and Adverse Events. It includes a note that the Quality Control Review Has Not Concluded and indicates Returned: 2024-06-24.SummaryDifference0.1%

- Check16 days agoNo Change Detected
- Check38 days agoChange DetectedNew operating-status notice and version update to v3.2.0; previous v3.1.0 version tag removed.SummaryDifference12%

- Check45 days agoChange DetectedVersion update: from v3.0.2 to v3.1.0. No other page content appears affected.SummaryDifference0.3%

- Check59 days agoChange DetectedPage version updated from v3.0.1 to v3.0.2; the 'Back to Top' link was removed.SummaryDifference0.7%

- Check66 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes in core content or other important factors.SummaryDifference0.7%

- Check73 days agoChange DetectedThe web page has undergone significant updates, including the addition of a facility name and location details, while several location-related terms have been removed.SummaryDifference13%

Stay in the know with updates to MGD013 and Brivanib in Liver Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the MGD013 and Brivanib in Liver Cancer Clinical Trial page.